Immix Biopharma, Inc.
IMMX
$2.00
-$0.12-5.66%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -23.13M | -20.90M | -21.61M | -21.89M | -19.02M |
| Total Depreciation and Amortization | 206.20K | 150.70K | 115.40K | 77.20K | 52.70K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.84M | 2.93M | 2.94M | 3.21M | 3.16M |
| Change in Net Operating Assets | 7.57M | 5.36M | 3.97M | 2.80M | 967.30K |
| Cash from Operations | -12.51M | -12.45M | -14.60M | -15.80M | -14.85M |
| Capital Expenditure | -974.00K | -943.50K | -1.18M | -683.70K | -451.10K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -974.00K | -943.50K | -1.18M | -683.70K | -451.10K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.11M | 0.00 | 15.95M | 16.54M | 26.66M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 0.00 | -58.80K |
| Cash from Financing | 1.11M | 0.00 | 15.95M | 16.54M | 26.60M |
| Foreign Exchange rate Adjustments | 34.00K | -1.20K | -3.60K | 52.80K | 18.00K |
| Miscellaneous Cash Flow Adjustments | 0.00 | 0.00 | 0.00 | -- | -- |
| Net Change in Cash | -12.34M | -13.40M | 172.10K | 108.00K | 11.32M |